| Literature DB >> 29721500 |
Mahbod Sahebi1, Mohamed M Hanafi1,2,3, Hasmah Mohidin4,5,6, M Y Rafii1, Parisa Azizi2, Abu Seman Idris7, A Fariz2, Rambod Abiri8, Sima Taheri9, Mehdi Moradpoor2.
Abstract
Entities:
Mesh:
Substances:
Year: 2018 PMID: 29721500 PMCID: PMC5867682 DOI: 10.1155/2018/1494157
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Fertilizer treatment levels for healthy and (+G) seedlings inoculated with G. boninense.
| T1 = seedling treated with N1 |
| T2 = seedling treated with N3 |
| T3 = seedling treated with P1 |
| T4 = seedling treated with P3 |
| T5 = seedling treated with K1 |
| T6 = seedling treated with K3 |
| T7 = seedling treated with N1P1K1 (N low, P low, K low) + BF |
| T8 = seedling treated with N2P2K2 (N optimum, P optimum, K optimum) + BF |
| T9 = seedling treated with N3P3K3 (N high, P high, K high) + BF |
| T10 = seedling treated with compound fertilizer (CF) |
Note. P and K optimum, N and K optimum, N and P optimum. All treatments with BF = basic fertilizer 2% MgO (source from kieserite) + micronutrients (TE). In the common commercial name (CF), where N stands for % N (12%), P % for P2O5 (12%), K for % K2O (17%), and Mg for % MgO (2%) + TE.
Fertilizer and rates applied in the nursery trials.
| Month | Urea | TSP | MOP | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N1 | N2 | N3 | P1 | P2 | P3 | K1 | K2 | K3 | |
| g/palm | |||||||||
|
| |||||||||
| 4 | 0.69 | 0.99 | 1.29 | 0.693 | 0.99 | 1.29 | 1.15 | 1.64 | 2.13 |
| 5 | 0.80 | 1.14 | 1.48 | 0.798 | 1.14 | 1.48 | 1.34 | 1.92 | 2.50 |
| 6 | 0.88 | 1.26 | 1.64 | 0.882 | 1.26 | 1.64 | 1.57 | 2.24 | 2.91 |
| 7 | 0.97 | 1.38 | 1.79 | 0.966 | 1.38 | 1.79 | 1.74 | 2.48 | 3.22 |
| 8 | 1.03 | 1.47 | 1.91 | 1.029 | 1.47 | 1.91 | 1.90 | 2.72 | 3.54 |
| 9 | 1.11 | 1.59 | 2.07 | 1.113 | 1.59 | 2.07 | 2.07 | 2.96 | 3.85 |
| 10 | 1.20 | 1.71 | 2.22 | 1.197 | 1.71 | 2.22 | 2.24 | 3.20 | 4.16 |
| 11 | 1.26 | 1.80 | 2.34 | 1.26 | 1.8 | 2.34 | 2.38 | 3.40 | 4.42 |
| 12 | 1.34 | 1.92 | 2.50 | 1.344 | 1.92 | 2.50 | 2.49 | 3.56 | 4.63 |
| 13 | 1.41 | 2.01 | 2.61 | 1.407 | 2.01 | 2.61 | 2.63 | 3.76 | 4.89 |
| 14 | 1.47 | 2.10 | 2.73 | 1.47 | 2.1 | 2.73 | 2.74 | 3.92 | 5.10 |
|
| |||||||||
| Total | 12.16 | 17.37 | 22.58 | 12.16 | 17.37 | 22.58 | 22.26 | 31.80 | 41.34 |
Note. Application of fertilizer in eleven months of experiment for growth analysis of oil palm seedlings. Amount of fertilizer needed for 1 replication for each level (g); TSP: triple superphosphate, MOP: muriate of potash. Level N1, P1, K1 (30%) less than N2, P2, and K2. Level N3, P3, and K3 (30%) more than N2, P2, and K2.
Effect of N, P, and K nutrition and different enzyme activities of healthy and Ganoderma infected oil palm seedlings.
| Week after inoculation |
| Control (Um L−1) |
| T2 | T5 | T6 | T8 | T10 |
|---|---|---|---|---|---|---|---|---|
| Glucanase activity | Effect of N, P2O5, and K2O nutrition on glucanase activity | |||||||
|
| ||||||||
| 1WAI | 10.097 ± 0.96 | 5.74 ± 0.33 | 10.43s | 9.93a | 7.4b | 10.2a | 7.2b | 4.9c |
| 4WAI | 2.397 ± 0.35 | 2.5 ± 0.47 | 6.74s | 3.3ab | 3.90a | 1.65c | 2.16bc | 1.25c |
| 8WAI | 16.837 ± 1.5 | 10.44 ± 1.15 | 11.06s | 17.78a | 9.75d | 16.2b | 14.56c | 9.9d |
| 12WAI | 3.197 ± 0.36 | 4.188 ± 0.69 | 8.66s | 3.48bc | 2.35c | 3.9b | 2.9bc | 5.87a |
|
| ||||||||
| Chitinase activity | Effect of N, P2O5, and K2O nutrition on chitinase activity | |||||||
|
| ||||||||
| 1WAI | 4.53 ±0.39 | 2.67 ± 0.46 | 11.54s | 3.18 | 4.07 | 4.27 | 3.93 | 2.57 |
| 4WAI | 1.57±0.26 | 1.96 ± 0.33 | 5.89s | 1.50 | 1.22 | 2.23 | 1.73 | 2.16 |
| 8WAI | 6.37± 0.76 | 4.36 ± 0.52 | 8.34s | 3.80c | 3.67c | 3.68a | 6.03ab | 5.65b |
| 12WAI | 3.28± 0.63 | 2.28 ± 0.39 | 5.16s | 2.32b | 2.16b | 4.97a | 2.75b | 1.73b |
|
| ||||||||
| PAL activity | Effect of N, P2O5, and K2O nutrition on PAL activity | |||||||
|
| ||||||||
| 1WAI | 10.9 ±0.89 | 8.90 ± 0.64 | 13.87s | 6.67c | 8.85bc | 11.30ab | 10.25ab | 12.45a |
| 4WAI | 12.08 ± 1.27 | 8.96 ± 0.77 | 11.58s | 7.75c | 7.50c | 16.15a | 9.65bc | 11.55b |
| 8WAI | 8.86 ± 0.90 | 5.66 ±0.48 | 11.72s | 5.25b | 8.00ab | 8.35a | 7.15ab | 7.55ab |
| 12WAI | 10.28 ± 1.33 | 4.4 ± 0.46 | 9.47s | 4.10b | 4.55b | 10.81a | 8.88a | 8.37a |
|
| ||||||||
| POX activity | Effect of N, P2O5, and K2O nutrition and BSR on POX Activity | |||||||
|
| ||||||||
| 1WAI | 20.65 ± 1.42 | 11.64 ± .91 | 12.82s | 15.55b | 11.80c | 15.75b | 19.26a | 18.35ab |
| 4WAI | 13.52 ± 1.74 | 9.96 ± 1.51 | 6.60s | 4.20c | 13.90ab | 15.25a | 12.25b | 12.1b |
| 8WAI | 6.86 ± 0.85 | 6.8 ±0.40 | 16.74s | 6.50a | 5.35a | 7.35a | 6.95a | 8.00a |
| 12WAI | 12.86 ± 1.43 | 14.82 ± .94 | 15.74s | 11.50c | 15.35ab | 17.35a | 11.95bc | 13.05bc |
Note. values are the means of three replicates; s indicates highly significant according to T-test at α′ = 0.05. WAI: week after inoculation; all the t-values are highly significant at 0.001%. Means with the same letter at a given parameter are not significantly different according to Duncan's Multiple Range Test (DMRT) at α = 0.05; values are the means of three replicates ± standard error. Treatments: T2 = N3+ BF + Ganoderma; T5 = K1 + BF + Ganoderma; T6 = K3 + BF + Ganoderma; T8 = N2P2K2 + BF + Ganoderma; T10 = control (compound fertilizer) + BF + Ganoderma.
Figure 1Effect of different levels of N, P, and K on glucanase activity in oil palm roots. Note. Values are the means of three replicates. Error bars represent the standard error. WAI: week after inoculation.
Figure 2Effect of different levels of N, P2O5, and K2O on chitinase activity in oil palm roots. Note. Values are the means of three replicates. Error bars represent the standard error. WAI: week after inoculation.
Figure 3Effect of different levels of N, P2O5, and K2O on PAL activity in oil palm roots. Note. Values are the means of three replicates. Error bars represent the standard error. WAI: week after inoculation.
Figure 4Effect of different levels of N, P2O5, and K2O on POX activity in oil palm roots. Note. Values are the means of three replicates. Error bars represent the standard error. WAI: week after inoculation.
Mass spectrometry for each compound and its molecular structure observed in different N, P, K combination of Ganoderma inoculated (+) and uninoculated oil palm seedlings.
| Sample |
| RT |
| Mass | Name | Molecular formula |
|---|---|---|---|---|---|---|
| T1 | (−) | 0.87 | 175.119 | 174.112 | Arginine | C6 H14 N4 O2 |
| T1 | (−) | 0.92 | 104.107 | 103.1 | 2-Amino-3-methyl-1-butanol | C5 H13 N O |
| T1 | (−) | 1 | 293.066 | 254.101 | Dyphylline | C10 H14 N4 O4 |
| T1 | (−) | 1.01 | 203.054 | 180.065 | Theobromine | C7 H8 N4 O2 |
| T1 | (−) | 1.02 | 435.062 | 180.065 | 4-Hydroxylevamisole glucuronide | C17 H20 N2 O7 S |
| T1 | (−) | 1.13 | 220.134 | 180.065 | Meperidinic acid | C13 H17 N O2 |
| T1 | (−) | 1.2 | 268.155 | 180.065 | Metoprolol acid | C14 H21 N O4 |
| T1 | (−) | 1.24 | 206.119 | 180.065 | Normeperidinic acid | C12 H15 N O2 |
| T1 | (−) | 1.25 | 282.171 | 180.065 | Benzenepropanoic acid, 4-[2-hydroxy-3- | C15 H23 N O4 |
| [(1-methylethyl)amino]propoxy]-(9CI) ASL 8123 | ||||||
| T1 | (−) | 1.93 | 417.18 | 180.065 | S-adenosylmethionine | C15 H23 N6 O5 S |
| T1 | (−) | 1.96 | 362.209 | 180.065 | Phe Pro Val | C19 H27 N3 O4 |
| T1 | (−) | 2.18 | 234.15 | 180.065 | Normeperidine | C14 H19 N O2 |
| T1 | (−) | 2.23 | 409.185 | 180.065 | Asn Met Gln | C14 H25 N5 O6 S |
| T1 | (−) | 2.31` | 409.185 | 180.065 | Asn Met Gln | C14 H25 N5 O6 S |
| T1 | (−) | 2.89 | 480.226 | 180.065 | Gln Phe Trp | C25 H29 N5 O5 |
| T1 | (−) | 3.17 | 236.166 | 180.065 | 5,7,9,11,13-tetradecapentaenoic acid | C14 H18 O2 |
| T1 | (-) | 3.23 | 480.224 | 180.065 | Gln Phe Trp | C25 H29 N5 O5 |
| T1 | (−) | 3.47 | 601.154 | 180.065 | Rhoifolin | C27 H30 O14 |
| T1 | (−) | 4.71 | 393.19 | 180.065 | Trp Gly Asn | C17 H21 N5 O5 |
| T1 | (−) | 4.89 | 541.263 | 180.065 | 17-Alpha, 21-dihydroxy-11,20-dioxo-5-beta-pregnan- | C27 H40 O11 |
| 3-alpha-yl-beta-d-glucuronide | ||||||
| T1 | (−) | 5.26 | 395.205 | 180.065 | Tyr Gly Arg | C17 H26 N6 O5 |
| T1 | (−) | 9.75 | 246.243 | 180.065 | 4,8-Dimethyl-dodecanoic acid | C14 H28 O2 |
| T1 | (−) | 12.1 | 274.275 | 180.065 | C16 sphinganine | C16 H35 N O2 |
| T1 | (−) | 12.1 | 274.275 | 180.065 | C16 sphinganine | C16 H35 N O2 |
| T1 | (−) | 12.2 | 230.249 | 180.065 | Myristaldehyde | C14 H28 O |
| T1 | (−) | 12.2 | 318.301 | 180.065 | Phytosphingosine | C18 H39 N O3 |
| T1 | (−) | 12.2 | 288.291 | 180.065 | C17 sphinganine | C17 H37 N O2 |
| T1 | (−) | 12.4 | 288.291 | 180.065 | C17 sphinganine | C17 H37 N O2 |
| T1 | (−) | 12.6 | 272.259 | 180.065 | 2R-aminohexadecanoic acid | C16 H33 N O2 |
| T1 | (−) | 12.8 | 288.291 | 180.065 | C17 Sphinganine | C17 H37 N O2 |
| T1 | (−) | 13.2 | 288.291 | 180.065 | C17 Sphinganine | C17 H37 N O2 |
| T1 | (−) | 13.3 | 244.265 | 180.065 | 9-Pentadecen-1-ol | C15 H30 O |
| T1 | (−) | 15 | 272.296 | 180.065 | 14-Methyl-8-hexadecen-1-ol | C17 H34 O |
| T1 | (−) | 15.5 | 272.296 | 180.065 | 14-Methyl-8-hexadecen-1-ol | C17 H34 O |
| T1 | (−) | 16.2 | 599.412 | 180.065 | Mytiloxanthin | C40 H54 O4 |
| T1 | (−) | 21.3 | 599.412 | 180.065 | Mytiloxanthin | C40 H54 O4 |
| T1 | (−) | 21.5 | 585.433 | 180.065 | Myxol | C40 H56 O3 |
| T1 | (−) | 21.5 | 601.427 | 180.065 | Capsanthin 3,6-epoxide | C40 H56 O4 |
| T1 | (−) | 21.8 | 429.374 | 180.065 | 25-Hydroxy-26,27-dimethylvitamin D3/ | C29 H48 O2 |
| 25-Hydroxy-26,27-dimethylcholecalciferol | ||||||
| T1 | (−) | 22.1 | 167.01 | 180.065 | 6-Hydroxy-2-hexynoic acid | C6 H8 O3 |
| T1 | (+) | 8.79 | 213.145 | 180.065 | meglumine | C7 H17 N O5 |
| T1 | (+) | 17.8 | 248.198 | 180.065 | Leu Val | C11 H22 N2 O3 |
| T1 | (+) | 17.8 | 192.135 | 180.065 | Lupinine | C10 H19 N O |
| T2 | (−) | 21.92 | 125.039 | 248.064 | Asp Asp | C8 H12 N2 O7 |
| T2 | (+) | 1.06 | 300.148 | 299.14 | Metoclopramide | C14 H22 Cl N3 O2 |
| T2 | (+) | 1.17 | 300.148 | 299.141 | Metoclopramide | C14 H22 Cl N3 O2 |
| T2 | (+) | 2.28 | 409.187 | 408.18 | Trp Phe Gly | C22 H24 N4 O4 |
| T2 | (+) | 5.24 | 395.208 | 356.246 | Dopexamine | C22 H32 N2 O2 |
| T2 | (+) | 17.77 | 243.139 | 242.132 | 6E,8E,14E-hexadecatriene-10,12-diynoic acid | C16 H18 O2 |
| T3 | (−) | 22.09 | 102.971 | 64.0082 | Ethyl chloride | C2 H5 Cl |
| T3 | (+) | 0.26 | 257.975 | 219.011 | 4-Amino-3-(5-chlorothien-2-YL) Butanoic acid | C8 H10 Cl N O2 S |
| T3 | (+) | 0.97 | 293.066 | 254.103 | Dyphylline | C10 H14 N4 O4 |
| T3 | (+) | 0.98 | 219.028 | 180.065 | Theobromine | C7 H8 N4 O2 |
| T3 | (+) | 1 | 277.0914 | 254.102 | Dyphylline | C10 H14 N4 O4 |
| T3 | (+) | 1.01 | 203.055 | 180.065 | Theobromine | C7 H8 N4 O2 |
| T3 | (+) | 1.03 | 435.061 | 396.097 | 4-Hydroxylevamisole glucuronide | C17 H20 N2 O7 S |
| T3 | (+) | 2 | 362.244 | 344.21 | Oxyphencyclimine | C20 H28 N2 O3 |
| T3 | (+) | 2.27 | 409.187 | 408.18 | Trp Phe Gly | C22 H24 N4 O4 |
| T3 | (+) | 2.9 | 480.227 | 479.219 | Gln Phe Trp | C25 H29 N5 O5 |
| T3 | (+) | 3.24 | 480.226 | 479.219 | Gln Phe Trp | C25 H29 N5 O5 |
| T3 | (+) | 3.63 | 264.161 | 246.127 | Santonin | C15 H18 O3 |
| T3 | (+) | 5.26 | 395.207 | 377.174 | Gln Lys Cys | C14 H27 N5 O5 S |
| T3 | (+) | 12.07 | 274.275 | 273.268 | C16 Sphinganine | C16 H35 N O2 |
| T3 | (+) | 12.49 | 409.16 | 370.197 | Lys His Ser | C15 H26 N6 O5 |
| T3 | (+) | 16 | 243.134 | 242.126 | Hydroxyamobarbital | C11 H18 N2 O4 |
| T3 | (+) | 18.2 | 419.243 | 418.236 | Met Arg Leu | C17 H34 N6 O4 S |
| T3 | (+) | 18.22 | 419.279 | 418.272 | Simvastatin | C25 H38 O5 |
| T3 | (+) | 18.23 | 375.253 | 374.245 | Digitoxigenin | C23 H34 O4 |
| T4 | (−) | 16.01 | 243.133 | 242.126 | Hydroxyamobarbital | C11 H18 N2 O4 |
| T4 | (+) | 0.99 | 277.091 | 254.102 | Dyphylline | C10 H14 N4 O4 |
| T4 | (+) | 1.01 | 138.058 | 120.025 | Sulfolane | C4 H8 O2 S |
| T4 | (+) | 1.95 | 362.243 | 344.209 | Oxyphencyclimine | C20 H28 N2 O3 |
| T4 | (+) | 2.25 | 409.186 | 408.178 | Trp Phe Gly | C22 H24 N4 O4 |
| T4 | (+) | 2.86 | 480.226 | 479.218 | Gln Phe Trp | C25 H29 N5 O5 |
| T4 | (+) | 3.2 | 480.226 | 479.219 | Gln Phe Trp | C25 H29 N5 O5 |
| T4 | (+) | 3.44 | 601.156 | 578.166 | Rhoifolin | C27 H30 O14 |
| T4 | (+) | 5.23 | 395.207 | 377.173 | Gln Lys Cys | C14 H27 N5 O5 S |
| T4 | (+) | 12.06 | 274.275 | 273.268 | C16 sphinganine | C16 H35 N O2 |
| T4 | (+) | 12.18 | 318.3 | 317.292 | Phytosphingosine | C18 H39 N O3 |
| T4 | (+) | 12.48 | 409.163 | 386.174 | Lys Cys His | C15 H26 N6 O4 S |
| T4 | (+) | 18.19 | 419.279 | 418.271 | Simvastatin | C25 H38 O5 |
| T4 | (+) | 21.49 | 585.433 | 584.426 | Myxol | C40 H56 O3 |
| T5 | (-) | 22.61 | 179.988 | 141.025 | 5-Acetyl-4-methylthiazole | C6 H7 N O S |
| T5 | (−) | 22.93 |
| 141.025 | 5-Acetyl-4-methylthiazole | C6 H7 N O S |
| T5 | (+) | 1.35 | 167.01 | 128.047 | 6-Hydroxy-2-hexynoic acid | C6 H8 O3 |
| T5 | (+) | 17.76 | 248.196 | 230.162 | Leu Val | C11 H22 N2 O3 |
| T5 | (+) | 17.77 | 192.136 | 169.147 | Lupinine | C10 H19 N O |
| T5 | (+) | 21.45 | 411.2875 | 410.2796 | 24,25-epoxy-1 alpha-hydroxy-22,22 | C27 H38 O3 |
| T5 | (+) | 21.46 | 343.2247 | 320.2348 | (+/−)14,15-EpETrE | C20 H32 O3 |
| T5 | (+) | 21.48 | 479.3497 | 456.3595 | Testosterone undecanoate | C30 H48 O3 |
| T5 | (+) | 21.65 | 343.2245 | 320.2353 | (+/−)14,15-EpETrE | C20 H32 O3 |
| T5 | (+) | 21.66 | 411.2861 | 388.297 | 1 | C25 H40 O3 |
| T5 | (+) | 21.94 | 125.0381 | 248.0616 | Dapsone | C12 H12 N2 O2 S |
| T6 | (−) | 17.77 | 248.1973 | 230.1635 | Leu Val | C11 H22 N2 O3 |
| T6 | (−) | 17.78 | 243.1331 | 242.1258 | Hydroxyamobarbital | C11 H18 N2 O4 |
| T6 | (−) | 21.56 | 839.4909 | 821.4566 | Tacrolimus metabolite M-VIII | C43 H67 N O14 |
| T6 | (−) | 21.65 | 498.9004 | 497.8933 | Perflubron | C8 Br F17 |
| T6 | (+) | 21.66 | 498.9008 | 497.8937 | Perflubron | C8 Br F17 |
| T6 | (+) | 21.95 | 125.0378 | 248.0611 | Dapsone | C12 H12 N2 O2 S |
| T7 | (−) | 1.2 | 179.9883 | 141.0251 | 5-Acetyl-4-methylthiazole | C6 H7 N O S |
| T7 | (−) | 17.77 | 248.1964 | 230.1627 | Leu Val | C11 H22 N2 O3 |
| T7 | (−) | 21.65 | 498.9009 | 497.8938 | Perflubron | C8 Br F17 |
| T7 | (+) | 17.51 | 301.1413 | 278.152 | Phthalic acid mono-2-ethylhexyl Ester | C16 H22 O4 |
| T7 | (+) | 17.77 | 192.1362 | 169.1473 | Lupinine | C10 H19 N O |
| T7 | (+) | 17.77 | 248.2013 | 247.194 | Lycopodine | C16 H25 N O |
| T7 | (+) | 20.14 | 282.2793 | 281.2721 | Oleoyl amine | C18 H35 N O |
| T7 | (+) | 21.44 | 411.2876 | 388.298 | 1 | C25 H40 O3 |
| T7 | (+) | 21.45 | 343.2242 | 320.235 | (+/−)14,15-EpETrE | C20 H32 O3 |
| T7 | (+) | 21.62 | 343.224 | 320.2347 | (+/−)14,15-EpETrE | C20 H32 O3 |
| T7 | (+) | 21.64 | 411.2862 | 388.297 | 1 | C25 H40 O3 |
| T7 | (+) | 22.15 | 167.011 | 128.0479 | 6-Hydroxy-2-hexynoic acid | C6 H8 O3 |
| T7 | (+) | 22.74 | 179.9885 | 141.0251 | 5-Acetyl-4-methylthiazole | C6 H7 N O S |
| T8 | (−) | 16.01 | 243.1334 | 242.1261 | Hydroxyamobarbital | C11 H18 N2 O4 |
| T8 | (−) | 17.77 | 243.1333 | 242.126 | Hydroxyamobarbital | C11 H18 N2 O4 |
| T8 | (+) | 17.76 | 248.1967 | 230.1631 | Leu Val | C11 H22 N2 O3 |
| T8 | (+) | 17.77 | 192.1347 | 174.1013 | Val Gly | C7 H14 N2 O3 |
| T8 | (+) | 21.61 | 395.2916 | 356.3286 | (+)-3-hydroxy behenic | C22 H44 O3 |
| T8 | (+) | 21.67 | 909.5463 | 886.5559 | Glc-GP(18:0/20:4(5Z,8Z,11Z,14Z)) | C47 H83 O13 P |
| T8 | (+) | 21.93 | 125.0388 | 248.0632 | Dapsone | C12 H12 N2 O2 S |
| T9 | (−) | 0.92 | 104.1065 | 103.0992 | 2-Amino-3-methyl-1-butanol | C5 H13 N O |
| T9 | (−) | 0.97 | 176.0109 | 137.0479 | p-aminobenzoic acid | C7 H7 N O2 |
| T9 | (−) | 0.98 | 293.0644 | 254.1012 | Dyphylline | C10 H14 N4 O4 |
| T9 | (−) | 0.99 | 160.0375 | 137.0483 | 3-Pyridylacetic acid | C7 H7 N O2 |
| T9 | (−) | 1.02 | 203.0545 | 180.0654 | Theobromine | C7 H8 N4 O2 |
| T9 | (−) | 1.03 | 435.0635 | 396.0998 | 4-Hydroxylevamisole glucuronide | C17 H20 N2 O7 S |
| T9 | (−) | 1.05 | 265.0252 | 226.0621 | Anthralin | C14 H10 O3 |
| T9 | (−) | 1.13 | 230.0935 | 191.1302 | Diethyltoluamide | C12 H17 N O |
| T9 | (−) | 1.19 | 287.1111 | 264.122 | 1-(5-Ketohexyl)-3-methylxanthine | C12 H16 N4 O3 |
| T9 | (−) | 1.21 | 268.1553 | 267.1479 | Metoprolol acid | C14 H21 N O4 |
| T9 | (−) | 1.26 | 282.1712 | 281.1639 | Benzenepropanoic acid | C15 H23 N O4 |
| T9 | (−) | 1.98 | 362.2078 | 361.2005 | Phe Val Pro | C19 H27 N3 O4 |
| T9 | (−) | 2.03 | 362.242 | 344.2085 | Oxyphencyclimine | C20 H28 N2 O3 |
| T9 | (−) | 2.28 | 411.2 | 388.2101 | Methyl 10,12,13,15-bisepidioxy- | C19 H32 O8 |
| 16-Hydroperoxy-8E-octadecenoate | ||||||
| T9 | (−) | 2.28 | 409.185 | 391.1507 | Asn Met Gln | C14 H25 N5 O6 S |
| T9 | (−) | 2.45 | 621.217 | 620.2091 | Diethylstilbestrol diglucuronide | C30 H36 O14 |
| T9 | (−) | 2.89 | 480.225 | 479.2173 | Gln Phe Trp | C25 H29 N5 O5 |
| T9 | (−) | 3.23 | 480.225 | 479.2173 | Gln Phe Trp | C25 H29 N5 O5 |
| T9 | (−) | 3.5 | 601.155 | 578.1652 | Rhoifolin | C27 H30 O14 |
| T9 | (−) | 5.2 | 395.174 | 377.1404 | Ofloxacin-N-oxide | C18 H20 F N3 O5 |
| T9 | (−) | 5.26 | 395.206 | 377.1723 | Gln Lys Cys | C14 H27 N5 O5 S |
| T9 | (−) | 5.69 | 205.062 | 182.0728 | 9-Hydroxyfluorene | C13 H10 O |
| T9 | (−) | 12.06 | 274.275 | 273.2672 | C16 sphinganine | C16 H35 N O2 |
| T9 | (−) | 12.19 | 318.3 | 317.2924 | Phytosphingosine | C18 H39 N O3 |
| T9 | (−) | 12.49 | 409.13 | 408.1232 | Ichthynone | C23 H20 O7 |
| T9 | (−) | 16.17 | 599.411 | 598.4032 | Mytiloxanthin | C40 H54 O4 |
| T9 | (−) | 20.08 | 797.52 | 774.5304 | 1,2 di-(9Z,12Z,15Z-octadecatrienoyl)-3- | C45 H74 O10 |
| O-beta-D-galactosyl-sn-glycerol | ||||||
| T9 | (−) | 21.5 | 585.433 | 584.425 | Myxol | C40 H56 O3 |
| T9 | (−) | 21.5 | 601.427 | 600.4195 | Capsanthin 3,6-epoxide | C40 H56 O4 |
| T9 | (−) | 21.69 | 646.254 | 645.2443 | Acarbose (Glucobay) | C25 H43 N O18 |
| T9 | (−) | 21.49 | 607.29 | 568.3266 | (3a,5b,7a)-23-carboxy-7-hydroxy-24-norcholan-3-yl, | C30 H48 O10 |
| b-D-glucopyranosiduronic acid | ||||||
| T10 | (−) | 0.97 | 293.065 | 254.1022 | Dyphylline | C10 H14 N4 O4 |
| T10 | (−) | 1.03 | 265.025 | 226.0623 | Anthralin | C14 H10 O3 |
| T10 | (−) | 1.17 | 287.112 | 264.1228 | 1-(5-Ketohexyl)-3-methylxanthine | C12 H16 N4 O3 |
| T10 | (−) | 2 | 362.243 | 344.2091 | Oxyphencyclimine | C20 H28 N2 O3 |
| T10 | (−) | 2.29 | 411.2 | 410.1925 | Flumethasone | C22 H28 F2 O5 |
| T10 | (−) | 2.29 | 409.185 | 408.1781 | Trp Phe Gly | C22 H24 N4 O4 |
| T10 | (−) | 2.45 | 621.218 | 620.2108 | Diethylstilbestrol diglucuronide | C30 H36 O14 |
| T10 | (−) | 2.92 | 480.225 | 479.2179 | Gln Phe Trp | C25 H29 N5 O5 |
| T10 | (−) | 3.25 | 480.225 | 479.2187 | Gln Phe Trp | C25 H29 N5 O5 |
| T10 | (−) | 3.64 | 264.159 | 246.1251 | Santonin | C15 H18 O3 |
| T10 | (−) | 5.23 | 395.207 | 377.1738 | Gln Cys Lys | C14 H27 N5 O5 S |
| T10 | (−) | 12.19 | 318.302 | 317.2943 | Phytosphingosine | C18 H39 N O3 |
| T10 | (−) | 12.72 | 288.291 | 287.2833 | C17 sphinganine | C17 H37 N O2 |
| T10 | (−) | 13.14 | 288.29 | 287.2824 | C17 sphinganine | C17 H37 N O2 |
| T10 | (−) | 14.93 | 316.321 | 298.2873 | 11-Methyl-octadecanoic acid | C19 H38 O2 |
| T10 | (−) | 14.97 | 272.295 | 254.2608 | 14-Methyl-8-hexadecen-1-ol | C17 H34 O |
| T10 | (−) | 15.51 | 304.286 | 286.2515 | 17-Hydroxy-heptadecanoic acid | C17 H34 O3 |
| T10 | (−) | 16.17 | 599.409 | 598.4011 | Mytiloxanthin | C40 H54 O4 |
| T10 | (−) | 17.76 | 248.197 | 230.1627 | Leu Val | C11 H22 N2 O3 |
| T10 | (−) | 21.31 | 597.238 | 574.2481 | p-hydroxy atorvastatin | C33 H35 F N2 O6 |
| T10 | (−) | 21.48 | 585.433 | 584.4252 | Myxol | C40 H56 O3 |
| T10 | (−) | 21.63 | 607.287 | 568.3253 | (3a,5b,7a)-23-carboxy-7-hydroxy-24-norcholan-3-yl, | C30 H48 O10 |
| b-D-Glucopyranosiduronic acid | ||||||
| T10 | (−) | 21.69 | 469.368 | 468.36 | 1 | C31 H48 O3 |
| tetradehydro-24a,24b-dihomovitamin D3 | ||||||
| T10 | (−) | 21.76 | 469.368 | 468.357 | 1 | C31 H48 O3 |
| -tetradehydro-24a,24b-dihomovitamin D3 | ||||||
| T10 | (−) | 21.77 | 429.375 | 428.367 | 25-hydroxy-26,27-dimethylvitamin D3/ | C29 H48 O2 |
| 25-hydroxy-26,27-dimethylcholecalciferol | ||||||
| T10 | (−) | 22.48 | 607.287 | 606.277 | Trandolapril glucuronide | C30 H42 N2 O11 |
| T10 | (+) | 1.04 | 265.027 | 226.064 | Anthralin | C14 H10 O3 |
| T10 | (+) | 1.07 | 300.148 | 299.141 | Metoclopramide | C14 H22 Cl N3 O2 |
| T10 | (+) | 1.17 | 300.147 | 299.14 | Metoclopramide | C14 H22 Cl N3 O2 |
| T10 | (+) | 1.98 | 362.245 | 344.211 | Oxyphencyclimine | C20 H28 N2 O3 |
| T10 | (+) | 2.27 | 409.187 | 408.18 | Trp Phe Gly | C22 H24 N4 O4 |
| T10 | (+) | 5.22 | 395.208 | 377.175 | Gln Cys Lys | C14 H27 N5 O5 S |
| T10 | (+) | 11.98 | 274.254 | 273.246 | 10Z,13Z,16Z-nonadecatrienenitrile | C19 H31 N |
| T10 | (+) | 12.15 | 230.248 | 212.214 | Myristaldehyde | C14 H28 O |
| T10 | (+) | 12.17 | 318.3 | 317.293 | Phytosphingosine | C18 H39 N O3 |
| T10 | (+) | 17.76 | 243.139 | 242.131 | 6E,8E,14E-Hexadecatriene-10,12-diynoic acid | C16 H18 O2 |
| T10 | (+) | 17.87 | 243.138 | 242.131 | 6E,8E,14E-Hexadecatriene-10,12-diynoic acid | C16 H18 O2 |
| T10 | (+) | 18.22 | 419.281 | 418.273 | Simvastatin | C25 H38 O5 |
| T10 | (+) | 21.29 | 645.275 | 606.312 | 1,25-Dihydroxy-20S-21-(3-hydroxy-3-methylbutyl) | C32 H44 F6 O4 |
| -23-yne-26,27-hexafluorovitamin D3 | ||||||
| T10 | (+) | 21.7 | 646.258 | 645.249 | Acarbose (Glucobay) | C25 H43 N O18 |
Figure 5Heatmap of 190 metabolite compounds in 10 types of NPK treatment oil palm seedling. A color matrix represents the mean values of the metabolite compounds in two biological replicates of oil palm. Characterization of the underlying metabolites is presented in Table 4.
Figure 6Fan plot showing all metabolite compounds of oil palm in both forms of control (−G) and inoculated with Ganoderma (+G), under different NPK treatments. Four different groups A, B, C, and D represent the m/z mean values of the metabolite compounds including flavonoids, phenylpropanoids, acyclic diterpenoids, and fatty acid derivative.
Figure 7Schematic model of oil palm, Ganoderma boninense, fertilizer regime interaction focusing on the role of plant lytic enzymes (Glycoforum: http://www.glycoforum.gr.jp). This schematic model indicates the contribution of PR proteins in response to macronutrients nutrition in oil palm with Ganoderma infection. Plants produce β-1,3-glucanases, chitinase, POX, and PAL during the process of pathogenesis for self- defense, and pathogens struggle against them. Application of NPK nutrients, especially K fertilizing, might either act as elicitors triggering the production of glucanase, chitinase, POX, and PAL activities or be involved in secondary metabolite profiling associated with induced resistance.